Diagnos Laboratorium Utama Tbk. vs Prodia Widyahusada Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Prodia Widyahusada Tbk. trades at Rp2,400 (market cap 2.23T, 351K 24h volume). The key difference: Prodia Widyahusada Tbk. is far larger — about 7.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 351K). Which is the better fit depends on your goals.
| DGNS | PRDA | |
|---|---|---|
Market Cap | 310.75B | 2.23T |
Volume | 963.6K | 351K |
Lot | 9.64K | 3.51K |
Turnover | 217.67M | 842.03M |
Average Price | 225.89 | 2,398.95 |
Value | 217.67M | 842.03M |
Indicative Equilibrium Price | 226 | 2,400 |
Indicative Equilibrium Volume | 1K | 65 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →